Related Experiment Video

Updated: May 30, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[Clinical evolution and cardiovascular complications in children with Kawasaki disease]

Jorge Alberto Morales-Quispe1, Nilda Espinola-Zavaleta, Rocío Caballero-Caballero

  • 1Hospital Materno Infantil, Instituto del Seguro Social del Estado de México y Municipios (ISSEMyM), Toluca, Estado de México, Mexico. niesza2001@hotmail.com

Revista Medica Del Instituto Mexicano Del Seguro Social
|August 16, 2011
PubMed

Insights

Early diagnosis and treatment of Kawasaki disease (KD) within 10 days of fever onset significantly reduces coronary artery abnormalities in children. Prompt intravenous immunoglobulin therapy is crucial for preventing serious cardiac complications.

Area of Science:

  • Pediatric Cardiology
  • Rheumatology
  • Infectious Diseases

Context:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Understanding KD presentation and treatment response is vital for pediatric care.

Purpose:

  • To detail the clinical presentation, manifestations, treatment outcomes, and coronary artery abnormalities in pediatric KD patients.
  • To evaluate the impact of early treatment on cardiac sequelae.

Summary:

  • This study reviewed 11 pediatric KD cases, noting common symptoms like non-exudative conjunctival injection and oral mucosal involvement.
  • Early treatment with intravenous immunoglobulin (IVIG) within 10 days of fever onset was associated with reduced coronary artery ectasia and aneurysms.
  • Patients receiving IVIG showed resolution of coronary artery changes, while those untreated developed aneurysms.

Impact:

  • Highlights Kawasaki disease as a significant cause of pediatric acquired heart disease.
  • Emphasizes the critical role of timely diagnosis and IVIG treatment in preventing long-term cardiac complications.
  • Informs clinical practice regarding the management of pediatric KD to improve patient outcomes and reduce cardiovascular risks.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...